- $12.22m
- $38.24m
- $1.02m
Brief: Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction
Brief: Pluri Got Letter From Nasdaq Approving Extension Of Extra 180 Days From Date Of Letter/Until April 15, 2024 To Regain Compliance
Brief: Pluri Files For Shelf Of Up To 16.3 Mln Common Shares By Selling Stockholders
Brief: Pluri Inc Receives Notice Of Delisting From Nasdaq
Brief: Pluri Prices $8.2 Million Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
Brief: Pluri Issues Letter To Shareholders Announcing New Tech Collaboration
U.S. STOCKS ON THE MOVE-Allego, GameStop, Worthington
U.S. STOCKS ON THE MOVE-Tilray, Moderna, Novavax, WeWork, Big Tech
U.S. STOCKS ON THE MOVE-Tesla, Dell, Citi Trends, Tilly's, Century Therapeutics
U.S. STOCKS ON THE MOVE-Bank stocks, Robinhood, Cardinal Health, Infosys, Zynga
U.S. RESEARCH ROUNDUP- Amphastar Pharmaceuticals, Bioxcel Therapeutics, Pure Storage
Pluristem plunges after COVID-19 treatment fails mid-stage trial
Pluristem to report data from COVID-19 therapy studies in Q4, shares up
Pluristem Therapeutics rises on disbursement offer from European bank
NASDAQ RESUMED AT 09:15 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:23 PM
U.S. STOCKS ON THE MOVE-Washington Prime, Abeona Therapeutics, Principia Biopharma
Pluristem Therapeutics: Up on deal with UAE stem cell firm to develop therapies